Applied Therapeutics, Inc. (APLT)
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
$1.15B
Dr. Shoshana Shendelman Ph.D.
26.00
New York, NY
May 09, 2019
-6.92
$-1.43
1.00
1.06
88,772.51%
-7,891.20
100.74
250,865.72
-5,646.85
1.06
-175.77%
-583.37%
Similar stocks (15)
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
ORIC Pharmaceuticals, Inc.
ORIC
C4 Therapeutics, Inc.
CCCC
Acrivon Therapeutics, Inc. Common Stock
ACRV
Seer, Inc.
SEER
BioAtla, Inc.
BCAB
PMV Pharmaceuticals, Inc.
PMVP
Gain Therapeutics, Inc.
GANX
HOOKIPA Pharma Inc.
HOOK
Anebulo Pharmaceuticals, Inc.
ANEB
Lantern Pharma Inc.
LTRN
Lyra Therapeutics, Inc.
LYRA
IN8bio, Inc.
INAB
Galera Therapeutics, Inc.
GRTX
ETF Exposure (15)
Invesco DWA SmallCap Momentum ETF
DWAS
0.48%
iShares Micro-Cap ETF
IWC
0.22575%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.1434751169%
iShares Russell 2000 Growth ETF
IWO
0.03994%
iShares Russell 2000 ETF
IWM
0.03387%
iShares Russell 2000 Value ETF
IWN
0.02694%
Schwab U.S. Small-Cap ETF
SCHA
0.0190471286%
iShares Morningstar Small-Cap ETF
ISCB
0.0127%
ALPS Medical Breakthroughs ETF
SBIO
0.0075%
ProShares Hedge Replication ETF
HDG
0.005323231599057022%
iShares Russell 3000 ETF
IWV
0.00206%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00176%
Schwab U.S. Broad Market ETF
SCHB
0.0013382592%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%
Similar stocks (15)
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
ORIC Pharmaceuticals, Inc.
ORIC
C4 Therapeutics, Inc.
CCCC
Acrivon Therapeutics, Inc. Common Stock
ACRV
Seer, Inc.
SEER
BioAtla, Inc.
BCAB
PMV Pharmaceuticals, Inc.
PMVP
Gain Therapeutics, Inc.
GANX
HOOKIPA Pharma Inc.
HOOK
Anebulo Pharmaceuticals, Inc.
ANEB
Lantern Pharma Inc.
LTRN
Lyra Therapeutics, Inc.
LYRA
IN8bio, Inc.
INAB
Galera Therapeutics, Inc.
GRTX
ETF Exposure (15)
Invesco DWA SmallCap Momentum ETF
DWAS
0.48%
iShares Micro-Cap ETF
IWC
0.22575%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.1434751169%
iShares Russell 2000 Growth ETF
IWO
0.03994%
iShares Russell 2000 ETF
IWM
0.03387%
iShares Russell 2000 Value ETF
IWN
0.02694%
Schwab U.S. Small-Cap ETF
SCHA
0.0190471286%
iShares Morningstar Small-Cap ETF
ISCB
0.0127%
ALPS Medical Breakthroughs ETF
SBIO
0.0075%
ProShares Hedge Replication ETF
HDG
0.005323231599057022%
iShares Russell 3000 ETF
IWV
0.00206%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00176%
Schwab U.S. Broad Market ETF
SCHB
0.0013382592%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Fidelity Nasdaq Composite Index ETF
ONEQ
0%